Brought to you by 
Inovio, Vaccine Research Center ally in flu vaccines
20 Aug 2009
Executive Summary
Inovio Biomedical (developing DNA vaccines for cancer and infectious diseases) and the National Inst. of Allergy & Infectious Diseases' Vaccine Research Center will ally in developing universal influenza vaccines and continue working on a vaccine for pandemic H1N1 swine flu strains.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Vaccines
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inovio, Vaccine Research Center ally in flu vaccines
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice